ArticleJournal of immune based therapies and vaccines2011

Safety, immunogenicity and preliminary efficacy of multiple-site vaccination with an Epidermal Growth Factor (EGF) based cancer vaccine in advanced non small cell lung cancer (NSCLC) patients.

Pedro C Rodriguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.